RGEN News and Press, Repligen Corporation From 05/30/24

2024-05-30 15:03:56 ET Summary Repligen Corporation stock has dropped 15% since our initial analysis of the stock just over six months ago. The company has posted a couple of quarterly earnings reports since then, and the company's balance sheet is in solid shape. That said, R...

2024-05-27 01:45:30 ET Summary Gilead is sitting at one of the lowest valuations in the Big Pharma sector, with a high and sustainable 4.6% dividend yield available for new buyers. The stock has an enviable track record of rising strongly in price when turmoil hits Wall Street and...

2024-05-26 09:55:00 ET Summary Parnassus Investments is a fundamental, bottoms-up investment firm offering responsible investment funds to the public. Parnassus Investments integrates comprehensive ESG evaluations with fundamental financial analysis to select investments. The Fund...

2024-05-23 17:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

WALTHAM, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be presenting at the following June investor conferences. William Blair’s 44 th Annual Growt...

2024-05-13 17:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

WALTHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating at the following May investor conferences. RBC Capital Markets’ 2024 Global Hea...

2024-05-03 07:15:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. During the first quarter of 2024, Baron Discovery Fund® (the Fund) was up 4.57% (...

2024-05-01 12:20:12 ET Repligen Corporation (RGEN) Q1 2024 Results Earnings Conference Call May 1, 2024, 08:30 AM ET Company Participants Sondra Newman - Head of Investor Relations Anthony Hunt - Chief Executive Officer Jason Garland - Chief Financial Officer ...

2024-05-01 07:32:52 ET More on Repligen Repligen misses top-line and bottom-line estimates; initiates FY24 outlook Seeking Alpha’s Quant Rating on Repligen Historical earnings data for Repligen Read the full article on Seeking Alpha For further...